相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bulk pancreatic cancer cells can convert into cancer stem cells(CSCs) in vitro and 2 compounds can target these CSCs
Xiaoyan Ning et al.
CELL CYCLE (2016)
Prospective of curcumin, a pleiotropic signalling molecule from Curcuma longa in the treatment of Glioblastoma
Pratibha Mehta Luthra et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Curcumin: A Natural Multitarget Treatment for Pancreatic Cancer
Amirhossein Sahebkar
INTEGRATIVE CANCER THERAPIES (2016)
Interaction of KRAS G-quadruplex with natural polyphenols: A spectroscopic analysis with molecular modeling
Rudradip Pattanayak et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2016)
Small molecule tolfenamic acid and dietary spice curcumin treatment enhances antiproliferative effect in pancreatic cancer cells via suppressing Sp1, disrupting NF-kB translocation to nucleus and cell cycle phase distribution
Riyaz Basha et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2016)
Curcumin inhibits hypoxia-induced epithelial-mesenchymal transition in pancreatic cancer cells via suppression of the hedgehog signaling pathway
Lei Cao et al.
ONCOLOGY REPORTS (2016)
Curcumin Induces Pancreatic Adenocarcinoma Cell Death Via Reduction of the Inhibitors of Apoptosis
Carlos J. Diaz Osterman et al.
PANCREAS (2016)
Targeting arachidonic acid pathway by natural products for cancer prevention and therapy
Nagendra Sastry Yarla et al.
SEMINARS IN CANCER BIOLOGY (2016)
The effects of curcumin (diferuloylmethane) on body composition of patients with advanced pancreatic cancer
Henrique A. Parsons et al.
ONCOTARGET (2016)
A polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human hepatocellular carcinoma
Bo Hu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Hyaluronic Acid Engineered Nanomicelles Loaded with 3,4-Difluorobenzylidene Curcumin for Targeted Killing of CD44+Stem-Like Pancreatic Cancer Cells
Prashant Kesharwani et al.
BIOMACROMOLECULES (2015)
Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer
Ganji Purnachandra Nagaraju et al.
CANCER LETTERS (2015)
Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells
Prashant Kesharwani et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2015)
Parenterally administrable nano-micelles of 3,4-difluorobenzylidene curcumin for treating pancreatic cancer
Prashant Kesharwani et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2015)
Curcumin Suppresses Phthalate-Induced Metastasis and the Proportion of Cancer Stem Cell (CSC)-like Cells via the Inhibition of AhR/ERK/SK1 Signaling in Hepatocellular Carcinoma
Cheng-Fang Tsai et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2015)
Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway
Zhiming Zhao et al.
MOLECULAR MEDICINE REPORTS (2015)
Curcumin and Omega-3 Fatty Acids Enhance NK Cell-Induced Apoptosis of Pancreatic Cancer Cells but Curcumin Inhibits Interferon-γ Production: Benefits of Omega-3 with Curcumin against Cancer
Milan Fiala
MOLECULES (2015)
Potential New Pharmacological Agents Derived From Medicinal Plants for the Treatment of Pancreatic Cancer
Haniye Azimi et al.
PANCREAS (2015)
Curcumin Modulates Pancreatic Adenocarcinoma Cell-Derived Exosomal Function
Carlos J. Diaz Osterman et al.
PLOS ONE (2015)
Biological and therapeutic activities, and anticancer properties of curcumin (Review)
Donatella Perrone et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)
Dissecting the Role of Curcumin in Tumour Growth and Angiogenesis in Mouse Model of Human Breast Cancer
Sabrina Bimonte et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Curcuminoids and ω-3 fatty acids with anti-oxidants potentiate cytotoxicity of natural killer cells against pancreatic ductal adenocarcinoma cells and inhibit interferon γ production
Ramesh C. Halder et al.
FRONTIERS IN PHYSIOLOGY (2015)
Deregulation of miR-146a expression in a mouse model of pancreatic cancer affecting EGFR signaling
Shadan Ali et al.
CANCER LETTERS (2014)
Curcumin inhibits cell growth and invasion through up-regulation of miR-7 in pancreatic cancer cells
Jia Ma et al.
TOXICOLOGY LETTERS (2014)
Active curcumin nanoparticles formed from a volatile microemulsion template
K. Margulis et al.
JOURNAL OF MATERIALS CHEMISTRY B (2014)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (TheracurminA®) in cancer patients
Masashi Kanai et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Novel synthetic curcumin analogues EF31 and UBS109 are potent DNA hypomethylating agents in pancreatic cancer
Ganji Purnachandra Nagaraju et al.
CANCER LETTERS (2013)
Novel Combinatorial Nanotechnology-Based Oral Chemopreventive Regimen Demonstrates Significant Suppression of Pancreatic Cancer Neoplastic Lesions
B. Karthik Grandhi et al.
CANCER PREVENTION RESEARCH (2013)
Upregulation of Extrinsic Apoptotic Pathway in Curcumin-Mediated Antiproliferative Effect on Human Pancreatic Carcinogenesis
Mahmoud Youns et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
Hideki Ueno et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Novel Curcumin-Loaded Magnetic Nanoparticles for Pancreatic Cancer Treatment
Murali M. Yallapu et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway
Xiao-Dong Sun et al.
ONCOLOGY REPORTS (2013)
Curcumin Inhibits Tumor Growth and Angiogenesis in an Orthotopic Mouse Model of Human Pancreatic Cancer
Sabrina Bimonte et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers
Masashi Kanai et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Curcumin Analogue CDF Inhibits Pancreatic Tumor Growth by Switching on Suppressor microRNAs and Attenuating EZH2 Expression
Bin Bao et al.
CANCER RESEARCH (2012)
Chemopreventive and Chemotherapeutic Potential of Curcumin in Breast Cancer
Dona Sinha et al.
CURRENT DRUG TARGETS (2012)
Curcumin Blocks Small Cell Lung Cancer Cells Migration, Invasion, Angiogenesis, Cell Cycle and Neoplasia through Janus Kinase-STAT3 Signalling Pathway
Cheng-Liang Yang et al.
PLOS ONE (2012)
Synergistic Effect of Garcinol and Curcumin on Antiproliferative and Apoptotic Activity in Pancreatic Cancer Cells
Mansi A. Parasramka et al.
JOURNAL OF ONCOLOGY (2012)
Innovative Preparation of Curcumin for Improved Oral Bioavailability
Hiroki Sasaki et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells
Yan Li et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer
Masashi Kanai et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Curcumin ameliorates oxaliplatin-induced chemoresistance in HCT116 colorectal cancer cells in vitro and in vivo
Lynne M. Howells et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer
Bin Bao et al.
PLOS ONE (2011)
被撤回的出版物: Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo (Retracted article. See vol. 102, pg. 143, 2016)
Preetha Anand et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Curcumin Inhibits Constitutive STAT3 Phosphorylation in Human Pancreatic Cancer Cell lines and Downregulation of Survivin/BIRC5 Gene Expression
W. Glienke et al.
CANCER INVESTIGATION (2010)
Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells
Li Lin et al.
CANCER RESEARCH (2010)
被撤回的出版物: Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF (Retracted article. See vol. 78, pg. 5466, 2018)
Shadan Ali et al.
CANCER RESEARCH (2010)
Inhibition of NFκB and Pancreatic Cancer Cell and Tumor Growth by Curcumin Is Dependent on Specificity Protein Down-regulation
Indira Jutooru et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Systemic Administration of Polymeric Nanoparticle-Encapsulated Curcumin (NanoCurc) Blocks Tumor Growth and Metastases in Preclinical Models of Pancreatic Cancer
Savita Bisht et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Curcumin Enhances the Effect of Cisplatin in Suppression of Head and Neck Squamous Cell Carcinoma via Inhibition of IKKβ Protein of the NFκB Pathway
Victor M. Duarte et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Advanced pancreatic carcinoma: current treatment and future challenges
Anastasios Stathis et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
Ron Epelbaum et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2010)
Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells
R. P. Sahu et al.
BRITISH JOURNAL OF CANCER (2009)
Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer
J. Shaikh et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group
Elizabeth Poplin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Fluorocurcumins as Cyclooxygenase-2 Inhibitor: Molecular Docking, Pharmacokinetics and Tissue Distribution in Mice
Subhash Padhye et al.
PHARMACEUTICAL RESEARCH (2009)
Curcumin: Preventive and therapeutic properties in laboratory studies and clinical trials
Alexios S. Strimpakos et al.
ANTIOXIDANTS & REDOX SIGNALING (2008)
Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects
Shaiju K. Vareed et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo
Vesna Milacic et al.
CANCER RESEARCH (2008)
Curcumin sensitizes human colorectal cancer xenografts in nude mice to γ-radiation by targeting nuclear factor-κB-regulated gene products
Ajaikumar B. Kunnumakkara et al.
CLINICAL CANCER RESEARCH (2008)
Phase II trial of curcumin in patients with advanced pancreatic cancer
Navneet Dhillon et al.
CLINICAL CANCER RESEARCH (2008)
A Pilot Cross-Over Study to Evaluate Human Oral Bioavailability of BCM-95® CG (Biocurcumax™), A Novel Bioenhanced Preparation of Curcumin
B. Antony et al.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells
Michael Sun et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Curcumin downregulates the inflammatory cytokines CXCL1 and-2 in breast cancer cells via NF kappa B
Beatrice E. Bachmeier et al.
CARCINOGENESIS (2008)
Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-κB pathway
Yvonne G. Lin et al.
CLINICAL CANCER RESEARCH (2007)
Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer:: A randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group
Richard Herrmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-κB-regulated gene products
Ajaikumar B. Kunnumakkara et al.
CANCER RESEARCH (2007)
Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway
Mao Li et al.
CANCER RESEARCH (2007)
Preclinical assessment of curcumin as a potential therapy for B-CLL
Peter C. Everett et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer
Volker Heinemann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
被撤回的出版物: Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells (Retracted article. See vol. 122, pg. 3247, 2016)
Zhiwei Wang et al.
CANCER (2006)
被撤回的出版物: Curcumin (diferuloylmethane) inhibits constitutive active NF-κB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells (Retracted article. See vol. 129, pg. 2762, 2011)
M Tomita et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer
H Oettle et al.
ANNALS OF ONCOLOGY (2005)
Liposome-encapsulated curcumin - In vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis
L Li et al.
CANCER (2005)
Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression
M Notarbartolo et al.
CANCER LETTERS (2005)
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer:: Results of a GERCOR and GISCAD phase III trial
C Louvet et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate
CMR Lima et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Nuclear factor-κB and IκB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis
L Li et al.
CANCER (2004)
Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance
RA Sharma et al.
CLINICAL CANCER RESEARCH (2004)
Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297
JD Berlin et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
分享论文
